FDA approves once-a-day pill for common skin cancer

Friday, July 24, 2015 - 13:50 in Health & Medicine

Stephen FellerSILVER SPRING, Md., July 24 (UPI) -- The FDA announced that it approved the once-a-day pill Odomzo for patients with recurrent basal cell carcinoma or who can't have surgery or radiation therapy.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net